Fire1
Private Company
Funding information not available
Overview
Fire1, founded in 2014 and headquartered in Dublin, Ireland, is a private medical device innovator targeting the global heart failure market. The company's lead product, NORM, is a remote monitoring system comprising an implantable IVC sensor, a wearable belt, and a smartphone app, designed to provide patients and clinicians with daily fluid status data. Currently in clinical trials across the US and Europe, Fire1 aims to reduce hospitalizations and give patients greater independence. The company originated from The Foundry, a prominent medical device incubator in Menlo Park, California.
Technology Platform
The NORM platform is a remote patient monitoring system for heart failure. It consists of an implantable sensor placed in the inferior vena cava (IVC) to directly measure fluid volume status, a wearable belt for daily wireless data transmission, and a smartphone app for patient and clinician data access and alerts.
Opportunities
Risk Factors
Competitive Landscape
Fire1 competes in the remote patient monitoring space for heart failure, which includes incumbent devices like Abbott's CardioMEMS (measures pulmonary artery pressure) and a growing array of non-invasive wearables and algorithmic software platforms. NORM's differentiation is its direct measurement of IVC diameter as a proxy for fluid volume, a novel approach compared to indirect metrics.